VERNALIS OXFORD LTD has a total of 56 patent applications. Its first patent ever was published in 1993. It filed its patents most often in EPO (European Patent Office), United States and United Kingdom. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are IYAKU BUNSHI SEKKEI KENKYUSHO, PFIZER RES & DEV and GALILEO PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 14 | |
#2 | United States | 9 | |
#3 | United Kingdom | 6 | |
#4 | Poland | 4 | |
#5 | Australia | 3 | |
#6 | WIPO (World Intellectual Property Organization) | 3 | |
#7 | Canada | 2 | |
#8 | China | 2 | |
#9 | Hong Kong | 2 | |
#10 | Norway | 2 | |
#11 | Brazil | 1 | |
#12 | EAPO (Eurasian Patent Organization) | 1 | |
#13 | Finland | 1 | |
#14 | Israel | 1 | |
#15 | Republic of Korea | 1 | |
#16 | Malaysia | 1 | |
#17 | Serbia | 1 | |
#18 | Ukraine | 1 | |
#19 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Foods and drinks |
# | Name | Total Patents |
---|---|---|
#1 | Davies Stephen John | 19 |
#2 | Pain Gilles | 16 |
#3 | Ayscough Andrew Paul | 12 |
#4 | Whittaker Mark | 10 |
#5 | Gillon Jean-Yves | 10 |
#6 | Beckett Raymond Paul | 10 |
#7 | East Stephen Peter | 7 |
#8 | Hunter Michael George | 6 |
#9 | Bombrun Agnes | 6 |
#10 | Spavold Zoe Marie | 6 |
Publication | Filing date | Title |
---|---|---|
WO2005019194A1 | Derivatives of hydroxamic acid as metalloproteinase inhibitors | |
GB0413808D0 | Antibacterial agents | |
GB0413813D0 | Antibacterial agents | |
GB0407862D0 | Antibacterial agents | |
GB0407963D0 | Antibacterial agents | |
GB0407865D0 | Antibacterial agents | |
GB0328632D0 | Metalloproteinase inhibitors | |
AU2002300119B2 | Antibacterial agents | |
EP1339400A1 | N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide deformylase for treating microbial infections | |
MY117874A | Metalloproteinase inhibitors |